These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33011725)

  • 1. High Prevalence of Small Intestinal Bacterial Overgrowth among Functional Dyspepsia Patients.
    Tziatzios G; Gkolfakis P; Papanikolaou IS; Mathur R; Pimentel M; Damoraki G; Giamarellos-Bourboulis EJ; Dimitriadis G; Triantafyllou K
    Dig Dis; 2021; 39(4):382-390. PubMed ID: 33011725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Shah A; Talley NJ; Jones M; Kendall BJ; Koloski N; Walker MM; Morrison M; Holtmann GJ
    Am J Gastroenterol; 2020 Feb; 115(2):190-201. PubMed ID: 31913194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Intestinal Bacterial Overgrowth In Various Functional Gastrointestinal Disorders: A Case-Control Study.
    Chuah KH; Wong MS; Tan PO; Lim SZ; Beh KH; Chong SCS; Zulkifli KK; Thalha AM; Mahadeva S; Lee YY
    Dig Dis Sci; 2022 Aug; 67(8):3881-3889. PubMed ID: 34417923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
    Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross sectional study.
    Piacentino D; Cantarini R; Alfonsi M; Badiali D; Pallotta N; Biondi M; Corazziari ES
    BMC Gastroenterol; 2011 Aug; 11():94. PubMed ID: 21871075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
    Ghoshal UC; Srivastava D; Ghoshal U; Misra A
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.
    Pyleris E; Giamarellos-Bourboulis EJ; Tzivras D; Koussoulas V; Barbatzas C; Pimentel M
    Dig Dis Sci; 2012 May; 57(5):1321-9. PubMed ID: 22262197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.
    Ghoshal UC; Nehra A; Mathur A; Rai S
    J Gastroenterol Hepatol; 2020 Jun; 35(6):922-931. PubMed ID: 31750966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Ursodeoxycholic Acid on Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia: A Pilot Randomized Controlled Trial.
    Kim BT; Kim KM; Kim KN
    Nutrients; 2020 May; 12(5):. PubMed ID: 32422942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.
    Shimura S; Ishimura N; Mikami H; Okimoto E; Uno G; Tamagawa Y; Aimi M; Oshima N; Sato S; Ishihara S; Kinoshita Y
    J Neurogastroenterol Motil; 2016 Jan; 22(1):60-8. PubMed ID: 26554916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.
    Carbone F; Holvoet L; Tack J
    Neurogastroenterol Motil; 2015 Aug; 27(8):1069-74. PubMed ID: 26220647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Symptom overlaps between functional heartburn, functional dyspepsia, and irritable bowel syndrome].
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):489-92. PubMed ID: 24941825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Ghoshal UC; Shukla R; Ghoshal U
    Gut Liver; 2017 Mar; 11(2):196-208. PubMed ID: 28274108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
    Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
    Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.
    Vanheel H; Carbone F; Valvekens L; Simren M; Tornblom H; Vanuytsel T; Van Oudenhove L; Tack J
    Am J Gastroenterol; 2017 Jan; 112(1):132-140. PubMed ID: 27958284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.